Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China
· Delayed Price · Currency is CNY 26.93
+0.47 (1.78%)
Apr 1, 2025, 3:00 PM CST
SHA:600332 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 2,835 | 4,056 | 3,967 | 3,720 | 2,915 | Upgrade
|
| Depreciation & Amortization | 834.87 | 929.44 | 743.83 | 676.99 | 644.2 | Upgrade
|
| Other Amortization | 101.33 | 55.88 | 49.83 | 43.53 | 35.35 | Upgrade
|
| Loss (Gain) From Sale of Assets | -11.12 | -12.03 | -0.69 | -0.69 | -2.95 | Upgrade
|
| Asset Writedown & Restructuring Costs | 2.93 | -0.42 | 7.06 | 3.08 | 2.89 | Upgrade
|
| Loss (Gain) From Sale of Investments | 39.18 | -288.71 | -417.58 | -390.47 | -335.7 | Upgrade
|
| Provision & Write-off of Bad Debts | 58.81 | 73.53 | 54.55 | 95.1 | 100.12 | Upgrade
|
| Other Operating Activities | 608.18 | 660.47 | 715.79 | 659.84 | 544.5 | Upgrade
|
| Change in Accounts Receivable | -255.91 | -417.27 | -1,992 | -1,627 | -572.17 | Upgrade
|
| Change in Inventory | -1,314 | -835.03 | -242.22 | -673.65 | -265.44 | Upgrade
|
| Change in Accounts Payable | 602.7 | -66.12 | 4,121 | 3,158 | -2,351 | Upgrade
|
| Operating Cash Flow | 3,442 | 4,104 | 6,999 | 5,673 | 585.19 | Upgrade
|
| Operating Cash Flow Growth | -16.11% | -41.37% | 23.36% | 869.52% | -88.35% | Upgrade
|
| Capital Expenditures | -1,128 | -1,628 | -1,384 | -1,255 | -876.5 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.36 | 13.93 | 1.49 | 6.61 | 6.15 | Upgrade
|
| Cash Acquisitions | -1.57 | - | 147.67 | -1.39 | - | Upgrade
|
| Divestitures | - | - | - | 32.57 | -34.75 | Upgrade
|
| Investment in Securities | -5,053 | -1,885 | -6,233 | 42.79 | -509.38 | Upgrade
|
| Other Investing Activities | 216.09 | 384.46 | 214.82 | 242.77 | 326.42 | Upgrade
|
| Investing Cash Flow | -5,964 | -3,115 | -7,253 | -931.57 | -1,088 | Upgrade
|
| Short-Term Debt Issued | - | 299.96 | 599.91 | - | - | Upgrade
|
| Long-Term Debt Issued | 9,954 | 9,604 | 9,696 | 8,826 | 8,918 | Upgrade
|
| Total Debt Issued | 9,954 | 9,904 | 10,296 | 8,826 | 8,918 | Upgrade
|
| Short-Term Debt Repaid | - | -900 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -8,648 | -9,646 | -8,422 | -8,943 | -6,159 | Upgrade
|
| Total Debt Repaid | -8,648 | -10,546 | -8,422 | -8,943 | -6,159 | Upgrade
|
| Net Debt Issued (Repaid) | 1,306 | -642.15 | 1,874 | -116.76 | 2,759 | Upgrade
|
| Common Dividends Paid | -2,251 | -1,585 | -1,491 | -1,266 | -1,290 | Upgrade
|
| Other Financing Activities | -61.59 | 249.35 | -337.16 | -111.17 | -29.95 | Upgrade
|
| Financing Cash Flow | -1,006 | -1,978 | 45.95 | -1,494 | 1,439 | Upgrade
|
| Foreign Exchange Rate Adjustments | 7.14 | 8.08 | -0.5 | 0.28 | -4.99 | Upgrade
|
| Net Cash Flow | -3,521 | -981.16 | -208.67 | 3,248 | 931.51 | Upgrade
|
| Free Cash Flow | 2,314 | 2,475 | 5,615 | 4,419 | -291.32 | Upgrade
|
| Free Cash Flow Growth | -6.50% | -55.92% | 27.08% | - | - | Upgrade
|
| Free Cash Flow Margin | 3.09% | 3.28% | 7.93% | 6.40% | -0.47% | Upgrade
|
| Free Cash Flow Per Share | 1.42 | 1.52 | 3.45 | 2.72 | -0.18 | Upgrade
|
| Cash Income Tax Paid | 2,729 | 3,140 | 2,759 | 2,873 | 2,638 | Upgrade
|
| Levered Free Cash Flow | 700.44 | 1,169 | 3,947 | 1,963 | -1,471 | Upgrade
|
| Unlevered Free Cash Flow | 961.79 | 1,448 | 4,219 | 2,224 | -1,244 | Upgrade
|
| Change in Net Working Capital | 1,017 | 906.44 | -2,005 | -277.34 | 2,938 | Upgrade
|
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.